米兰系统报告涎腺细胞学:东南亚三级中心1384例回顾分析
该研究回顾性分析东南亚三级转诊中心10年内1384例涎腺细针穿刺(FNA),按米兰系统(MSRSGC)分类并与组织学对照。结果显示各分类恶性风险(ROM)从良性肿瘤0.5%至恶性100.0%不等,非诊断性率28.9%较高,非肿瘤性ROM 17.5%高于文献,SUMP的ROM 17.1%低于文献,非肿瘤性假阴性均为富含淋巴样病变。
要点
- 各MSRSGC分类的ROM:非诊断性10.0%、非肿瘤性17.5%、AUS 29.5%、良性肿瘤0.5%、SUMP 17.1%、可疑恶性83.3%、恶性100.0%。
- 非诊断性率28.9%较高,可能反映分析前因素;恶性肿瘤率3.2%较低,可能与人群和医疗可及性有关。
- 非肿瘤性类别假阴性均为富含淋巴样病变,需关注此类病变的鉴别诊断。
核心结论
- 这是现有文献中较大规模单机构研究之一,记录了MSRSGC各分类的发生率和恶性风险(ROM)。
- 研究强调富含淋巴样病变在涎腺细胞学诊断中的特殊挑战。
研究设计与样本
- 回顾性分析10年内涎腺细针穿刺(FNA)病例,按MSRSGC分类,并与组织学结果进行细胞-组织学对照。
- 共评估1384例涎腺FNA,其中421例有相应组织学结果。
主要发现
- 分类分布:非诊断性28.9%、非肿瘤性18.0%、AUS 9.8%、良性肿瘤32.9%、SUMP 5.7%、可疑恶性1.6%、恶性3.2%。
- ROM:非诊断性10.0%、非肿瘤性17.5%、AUS 29.5%、良性肿瘤0.5%、SUMP 17.1%、可疑恶性83.3%、恶性100.0%。
- 非肿瘤性ROM 17.5%高于文献报道的5%~10%,可能与切除病例数较少有关。
- SUMP的ROM 17.1%低于文献报道的21%~44%,可能反映组织学上良性基底样肿瘤比例较高。
- 非肿瘤性类别中所有假阴性病例均为富含淋巴样病变。
关键数值与推荐
- MSRSGC分类及对应ROM:非诊断性10.0%、非肿瘤性17.5%、AUS 29.5%、良性肿瘤0.5%、SUMP 17.1%、可疑恶性83.3%、恶性100.0%。
临床怎么用
- 在涎腺FNA报告中应用MSRSGC分类可提供风险分层和管理依据。
- 对富含淋巴样病变的非肿瘤性病例应警惕假阴性可能,必要时结合临床和影像学随访。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The Milan System for Reporting Salivary Gland Cytopathology (MSRSGC) aims to provide a common language for risk stratification and management. We examine the incidence of MSRSGC categories and the corresponding risk of malignancy (ROM) within a tertiary referral centre in Southeast Asia. METHODS: Salivary gland fine needle aspirations (FNAs) performed within a 10-year period were classified retrospectively according to the MSRSGC. Cytohistologic correlation was performed. The results were compared with the existing literature, including Asian and Western studies. RESULTS: A total of 1384 salivary gland FNAs were evaluated, 421 with corresponding histology. The category distribution was: nondiagnostic, 28.9%; nonneoplastic, 18.0%; atypia of undetermined significance (AUS), 9.8%; benign neoplasm, 32.9%; salivary gland neoplasm of uncertain malignant potential (SUMP), 5.7%; suspicious for malignancy, 1.6%; and malignant, 3.2%. The ROMs were: nondiagnostic, 10.0%; nonneoplastic, 17.5%; AUS, 29.5%; benign neoplasm, 0.5%; SUMP, 17.1%; suspicious for malignancy, 83.3%; and malignant, 100.0%. Our relatively high nondiagnostic rate likely reflects preanalytical factors, whereas our low malignancy rate may be related to population and health care accessibility. Our nonneoplastic ROM was 17.5% compared with 5% to 10% in the literature, likely due to the relatively small number of excised cases; the ROM for SUMP was 17.1% versus 21% to 44% in the literature, possibly reflecting a significant proportion of benign basaloid neoplasms on histology. Interestingly, all false-negative cases in the nonneoplastic category were lymphoid-rich lesions. CONCLUSION: This is one of the largest single-institution studies in the existing literature documenting both the incidence and ROMs of MSRSGC categories. We also highlight specific challenges surrounding lymphoid-rich lesions.
引用
- Lee JJL, Tan HM, Chua DYS, et al. The Milan system for reporting salivary gland cytology: A retrospective analysis of 1384 cases in a tertiary Southeast Asian institution. Cancer Cytopathol. 2020. PMID: 32022995. doi:10.1002/cncy.22245
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。